This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/chemspider/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/chebi/
n9http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/wikipedia/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/kegg-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/pdb/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n17http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/pubchem-substance/
n5http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02083/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02083
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB02083 n16:DB02083
dcterms:title
Dimethylglycine
adms:identifier
n7:Dimethylglycine n10:DMG n11:673 n12:DB02083 n13:C01026 n14:17724 n15:653 n17:46507083
n3:synthesisReference
Roger V. Kendall, John W. Lawson, "Dimethylglycine enhancement of antibody production." U.S. Patent US5118618, issued December, 1982.
n3:IUPAC-Name
n5:271B6304-363D-11E5-9242-09173F13E4C5
n3:InChI
n5:271B630A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n5:271B6309-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n5:271B6306-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n5:271B6307-363D-11E5-9242-09173F13E4C5
n3:SMILES
n5:271B6308-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n5:271B6302-363D-11E5-9242-09173F13E4C5
n3:logP
n5:271B6300-363D-11E5-9242-09173F13E4C5 n5:271B6303-363D-11E5-9242-09173F13E4C5 n5:271B631C-363D-11E5-9242-09173F13E4C5
n3:logS
n5:271B6301-363D-11E5-9242-09173F13E4C5
n3:pKa
n5:271B631D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n5:271B6310-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n5:271B6311-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n5:271B630B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n5:271B630C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n5:271B630E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n5:271B630D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n5:271B630F-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
1118-68-9
n3:Bioavailability
n5:271B6316-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n5:271B631B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n5:271B6318-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n5:271B6319-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n5:271B631A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n5:271B6315-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n5:271B6314-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n5:271B6317-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n5:271B6305-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n5:271B6312-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n5:271B6313-363D-11E5-9242-09173F13E4C5